Elanco Animal Health Incorporated (ELAN)
Largest Insider Buys in Sector
ELAN Stock Price History Chart
ELAN Stock Performance
About Elanco Animal Health Incorporated
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, …
Insider Activity of Elanco Animal Health Incorporated
Over the last 12 months, insiders at Elanco Animal Health Incorporated have bought $2.23M and sold $0 worth of Elanco Animal Health Incorporated stock.
On average, over the past 5 years, insiders at Elanco Animal Health Incorporated have bought $2.69M and sold $3.25B worth of stock each year.
Highest buying activity among insiders over the last 12 months: Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) — $2.6M. HOOVER R DAVID (director) — $1.61M. DOYLE WILLIAM F (director) — $1.5M.
The last purchase of 3,500 shares for transaction amount of $51,974 was made by Harrington Michael J (director) on 2024‑08‑22.
List of Insider Buy and Sell Transactions, Elanco Animal Health Incorporated
| 2024-08-22 | director | 3,500 0.0007% | $14.85 | $51,974 | -3.35% | |||
| 2024-08-12 | PRESIDENT, CEO AND DIRECTOR | 100,000 0.02% | $13.01 | $1.3M | +9.01% | |||
| 2024-05-21 | director | 15,000 0.0031% | $16.98 | $254,700 | -14.00% | |||
| 2024-03-08 | director | 3,100 0.0006% | $16.29 | $50,494 | -11.85% | |||
| 2024-03-08 | director | 15,000 0.003% | $16.30 | $244,500 | -11.85% | |||
| 2024-03-06 | director | 20,000 0.0041% | $16.14 | $322,808 | -9.66% | |||
| 2023-03-14 | director | 5,000 0.001% | $9.55 | $47,750 | +22.55% | |||
| 2023-03-13 | director | 5,000 0.001% | $9.46 | $47,288 | +23.79% | |||
| 2023-03-10 | PRESIDENT, CEO AND DIRECTOR | 15,000 0.0031% | $9.60 | $143,972 | +19.75% | |||
| 2023-03-03 | director | 10,000 0.002% | $11.13 | $111,300 | +1.35% | |||
| 2022-11-11 | director | 7,500 0.0015% | $13.24 | $99,267 | -16.80% | |||
| 2022-09-09 | 20,000 0.0041% | $15.18 | $303,614 | -21.00% | ||||
| 2022-09-09 | SEE REMARKS | 13,400 0.0027% | $14.90 | $199,660 | -21.00% | |||
| 2022-09-09 | PRESIDENT, CEO AND DIRECTOR | 30,000 0.006% | $14.54 | $436,146 | -21.00% | |||
| 2022-09-09 | 20,000 0.0041% | $15.03 | $300,500 | -21.00% | ||||
| 2022-05-20 | 20,000 0.0039% | $23.33 | $466,538 | -46.79% | ||||
| 2022-05-11 | 20,000 0.0043% | $22.03 | $440,568 | -37.18% | ||||
| 2022-03-02 | director | 10,000 0.002% | $29.00 | $290,000 | -46.97% | |||
| 2022-03-01 | director | 10,000 0.002% | $28.66 | $286,645 | -46.86% | |||
| 2022-03-01 | director | 2,000 0.0004% | $28.48 | $56,958 | -46.86% |
Insider Historical Profitability
| HOOVER R DAVID | director | 185000 0.0374% | $11.85 | 23 | 0 | <0.0001% |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 145000 0.0293% | $11.85 | 7 | 0 | <0.0001% |
| Harrington Michael J | director | 81094 0.0164% | $11.85 | 6 | 0 | <0.0001% |
| DOYLE WILLIAM F | director | 76330 0.0154% | $11.85 | 2 | 0 | |
| BILBREY JOHN P | director | 41722 0.0084% | $11.85 | 6 | 0 | <0.0001% |
Institutional Investor Ownership
| Dodge & Cox | $1.37B | 16.97 | 83.85M | -0.16% | -$2.15M | 0.8 | |
| PRIMECAP Management Co | $860.97M | 10.7 | 52.89M | +4.51% | +$37.2M | 0.63 | |
| The Vanguard Group | $801.92M | 9.97 | 49.26M | -0.42% | -$3.43M | 0.02 | |
| BlackRock | $433.7M | 5.39 | 26.64M | -4.12% | -$18.62M | 0.01 | |
| T. Rowe Price | $360.43M | 4.48 | 22.14M | +4% | +$13.88M | 0.04 |